Ushbu ishga iqtibos qilgan ishlar

4 ta ish

Ish: Emerging strategies to reduce the side effects of CAR-T cell therapy: focusing on gene editing and nanotechnology

1. Integrating RNA technologies with CAR-T cell therapy: strategies to overcome current limitations and expand clinical applications

   Alexey Yumashev, Matlyuba Sanoyeva, Emma Muradova +6

   Sharh maqola20260 iqtibos

   ABIABI:AkademIndex/2026.review-article.ndxz6ed7

2. Trogocytosis in cancer immunity and cellular immunotherapy: mechanisms, therapeutic challenges, and translational opportunities

   Фарида Муиновна Хамидова, Zarina Babaeva, Khasan Jafarov +6

   MaqolaImmunotherapy and Immune ResponsesClinical & Translational Oncology20260 iqtibos

   ABIABI:AkademIndex/2026.article.025804

3. Beyond Conventional Chimeric Antigen Receptors: Expanding the Targetable Antigen Landscape in Chimeric Antigen Receptor-T Cell Therapy

   Umida Yoziyeva, Alexey Yumashev, Shakhodat Kobilova +5

   Maqola20260 iqtibos

   ABIABI:AkademIndex/2026.article.038084

4. Leveraging Chimeric Antigen Receptor-T Cell Therapy for the Treatment of Multiple Sclerosis: Bridging Oncology and Neurology

   Matlyuba Sanoyeva, Наргиза Насирдинова, M. Gulova +5

   Maqola20260 iqtibos

   ABIABI:AkademIndex/2026.article.039242